Brodin BA - Search Results

1

Organ uptake, toxicity and skin clearance of ruthenium contrast agents monitored in vivo by x-ray fluorescence.

Vogt C, Saladino GM, Shaker K, Arsenian-Henriksson M, Hertz HM, Toprak MS, Brodin BA. Vogt C, et al. Among authors: brodin ba. Nanomedicine (Lond). 2023 Aug;18(18):1161-1173. doi: 10.2217/nnm-2023-0061. Epub 2023 Sep 4. Nanomedicine (Lond). 2023. PMID: 37665018 Free article.

2

A novel fusion gene, SYT-SSX4, in synovial sarcoma.

Skytting B, Nilsson G, Brodin B, Xie Y, Lundeberg J, Uhlén M, Larsson O. Skytting B, et al. J Natl Cancer Inst. 1999 Jun 2;91(11):974-5. doi: 10.1093/jnci/91.11.974. J Natl Cancer Inst. 1999. PMID: 10359553 No abstract available.

3

Synthesis, Physicochemical Characterization, and Cytotoxicity Assessment of Rh Nanoparticles with Different Morphologies-as Potential XFCT Nanoprobes.

Li Y, Saladino GM, Shaker K, Svenda M, Vogt C, Brodin B, Hertz HM, Toprak MS. Li Y, et al. Nanomaterials (Basel). 2020 Oct 27;10(11):2129. doi: 10.3390/nano10112129. Nanomaterials (Basel). 2020. PMID: 33120889 Free PMC article.

4

Optical and X-ray Fluorescent Nanoparticles for Dual Mode Bioimaging.

Saladino GM, Vogt C, Li Y, Shaker K, Brodin B, Svenda M, Hertz HM, Toprak MS. Saladino GM, et al. ACS Nano. 2021 Mar 23;15(3):5077-5085. doi: 10.1021/acsnano.0c10127. Epub 2021 Feb 15. ACS Nano. 2021. PMID: 33587608 Free PMC article.

5

Carbon Quantum Dots Conjugated Rhodium Nanoparticles as Hybrid Multimodal Contrast Agents.

Saladino GM, Kilic NI, Brodin B, Hamawandi B, Yazgan I, Hertz HM, Toprak MS. Saladino GM, et al. Nanomaterials (Basel). 2021 Aug 24;11(9):2165. doi: 10.3390/nano11092165. Nanomaterials (Basel). 2021. PMID: 34578481 Free PMC article.

6

XFCT-MRI hybrid multimodal contrast agents for complementary imaging.

Saladino GM, Vogt C, Brodin B, Shaker K, Kilic NI, Andersson K, Arsenian-Henriksson M, Toprak MS, Hertz HM. Saladino GM, et al. Nanoscale. 2023 Feb 2;15(5):2214-2222. doi: 10.1039/d2nr05829d. Nanoscale. 2023. PMID: 36625091

7

Iterative nanoparticle bioengineering enabled by x-ray fluorescence imaging.

Saladino GM, Brodin B, Kakadiya R, Toprak MS, Hertz HM. Saladino GM, et al. Sci Adv. 2024 Mar 22;10(12):eadl2267. doi: 10.1126/sciadv.adl2267. Epub 2024 Mar 22. Sci Adv. 2024. PMID: 38517973 Free PMC article.

8

SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth.

Ma L, Maruwge W, Strambi A, D'Arcy P, Pellegrini P, Kis L, de Milito A, Lain S, Brodin B. Ma L, et al. Cell Death Dis. 2014 Oct 23;5(10):e1483. doi: 10.1038/cddis.2014.385. Cell Death Dis. 2014. PMID: 25341037 Free PMC article.

9

CINSARC: a new look into an old concept gives hope for new treatments for synovial sarcomas.

Brodin BA. Brodin BA. Transl Pediatr. 2013 Apr;2(2):70-2. doi: 10.3978/j.issn.2224-4336.2013.04.04. Transl Pediatr. 2013. PMID: 26835293 Free PMC article. No abstract available.

10

Drug sensitivity testing on patient-derived sarcoma cells predicts patient response to treatment and identifies c-Sarc inhibitors as active drugs for translocation sarcomas.

Brodin BA, Wennerberg K, Lidbrink E, Brosjö O, Potdar S, Wilson JN, Ma L, Moens LN, Hesla A, Porovic E, Bernhardsson E, Papakonstantinou A, Bauer H, Tsagkozis P, von Sivers K, Wejde J, Östling P, Kallioniemi O, Stragliotto CL. Brodin BA, et al. Br J Cancer. 2019 Feb;120(4):435-443. doi: 10.1038/s41416-018-0359-4. Epub 2019 Feb 12. Br J Cancer. 2019. PMID: 30745580 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

31 results

Search Page